Beck's cognitive triad

Last updated
A diagram showing Beck's cognitive triad Beck's CognitiveTriad.png
A diagram showing Beck's cognitive triad

Beck's cognitive triad, also known as the negative triad, [1] [2] is a cognitive-therapeutic view of the three key elements of a person's belief system present in depression. It was proposed by Aaron Beck in 1967. [3] The triad forms part of his cognitive theory of depression [4] and the concept is used as part of CBT, particularly in Beck's "Treatment of Negative Automatic Thoughts" (TNAT) approach.

Contents

The triad involves "automatic, spontaneous and seemingly uncontrollable negative thoughts" [5] about:

Examples of this negative thinking include:

Beck's cognitive model of depression

From a cognitive perspective, depressive disorders are characterized by people's dysfunctional negative views of themselves, their life experience (and the world in general), and their future—the cognitive triad.

People with depression often view themselves as unlovable, helpless, doomed or deficient. They tend to attribute their unpleasant experiences to their presumed physical, mental, and/or moral deficits. [6] They tend to feel excessively guilty, believing that they are worthless, blameworthy, and rejected by self and others. They may have a very difficult time viewing themselves as people who could ever succeed, be accepted, or feel good about themselves and this may lead to withdrawal and isolation, which further worsens the mood. [7]

Cognitive distortions

Examples of some of the cognitive biases used by depressed individuals, according to cognitive theories including Beck's cognitive model. People with depression may be taught how to identify and alter these biases as part of Cognitive Behavioural Therapy. Common Cognitive Biases.png
Examples of some of the cognitive biases used by depressed individuals, according to cognitive theories including Beck's cognitive model. People with depression may be taught how to identify and alter these biases as part of Cognitive Behavioural Therapy.

Beck proposes that those with depression develop cognitive distortions, a type of cognitive bias sometimes also referred to as faulty or unhelpful thinking patterns. Beck referred to some of these biases as "automatic thoughts", suggesting they are not entirely under conscious control. People with depression will tend to quickly overlook their positive attributes and disqualify their accomplishments as being minor or meaningless. They may also misinterpret the care, good will, and concern of others as being based on pity or susceptible to being lost easily if those others knew the “real person" and this fuels further feelings of guilt. The main cognitive distortions according to Beck are summarised below: [1] [8]

Depressed people view their lives as devoid of pleasure or reward, presenting insuperable obstacles to achieving their important goals. This is often manifested as a lack of motivation and leads to the depressed person feeling further withdrawal and isolation as they may be seen as lazy by others. Everything seems and feels “too hard to manage” and other people are seen as punishing (or potentially so). They believe that their troubles will continue indefinitely, and that the future will only bring further hardship, deprivation, and frustration. “Paralysis of the will” results from the depressed patients' pessimism and hopelessness. Expecting their efforts to end in failure, they are reluctant to commit themselves to growth-oriented goals, and their activity level drops. Believing that they cannot affect the outcome of various situations, they experience a desire to avoid such situations. [7]

Suicidal wishes are seen as an extreme expression of the desire to escape from problems that appear to be uncontrollable, interminable, and unbearable. [10]

Negative self-schemata

Beck also believed that a depressed person will, often from childhood experiences, hold a negative self-schema. [11] This schema may originate from negative early experiences, such as criticism, abuse or bullying. [12] Beck suggests that people with negative self-schemata are liable to interpret information presented to them in a negative manner, leading to the cognitive distortions outlined above. The pessimistic explanatory style, which describes the way in which depressed or neurotic people react negatively to certain events, is an example of the effect of these schemata on self-image. This explanatory style involves blaming oneself for negative events outside of their control or the behaviour of others (personalisation), believing that such events will continue forever and letting these events significantly affect their emotional wellbeing.

Measuring aspects of the triad

A number of instruments have been developed to attempt to measure negative cognition in the three areas of the triad. [13] The Beck Depression Inventory (BDI) is a well-known questionnaire for scoring depression based on all three aspects of the triad. Other examples include the Beck Hopelessness Scale [14] for measuring thoughts about the future and the Rosenberg Self-Esteem Scale [15] for measuring views of the self. The Cognitive Triad Inventory (CTI) was developed by Beckham et al. [13] to attempt to systematically measure the three aspects of Beck's triad. The CTI aims to quantify the relationship between "therapist behaviour in a single treatment session to changes in the cognitive triad" and "patterns of changes to the triad to changes in overall depressive mood". [13] This inventory has since been adapted for use with children and adolescents in the CTI-C, developed by Kaslow et al. [16]

Biological correlates of the cognitive model

Although extensive research supports the cognitive model, there still remained the question of why only a proportion of people exposed to adverse stressors become depressed experiencing negative cognitive biases and pessimistic explanatory style. [17] Many researchers believed there was "blue gene" [18] responsible for impacting neural functioning affecting hyperactivity to negative experiences leading to depression. Technological advancements in the last few decades have indeed been able to verify these genetic variations and explain the structure of the relationship between adverse events, neurobiological disregulation [19] and cognition. [20]

Genetic Vulnerability

Caspi et al. (2003) found that individuals possessing one or two copies of the short genetic variant of the serotonin transporter gene (5HTTLPR) were more prone to experiencing depression following exposure to an adverse life event. [21] The findings of this study have then been replicated by researchers like Kendler et al. (2005) who showed children experiencing maltreatment and carried the 5HTTLPR gene displayed increased sensitivity to severe depression as adults, [22] Vrshek-Schallhorn et al. (2014) who displayed the interaction between stressful life events and the 5HTTLPR gene predicted the onset of depression, [23] Conway et al. (2012) who showed risk of depression as a result of 5HTTLPR gene increasing negative appraisals of adverse events etc. A meta-analysis done by Karg et al. (2011) confirms the moderating effects of the 5HTTLPR gene on perception of stressful events and depression. [24] Additionally, the moderation by this genetic polymorphism seems to occur across a varied levels of stressors, ranging from mild to traumatic.

The relationship between 5HTTLPR and depression has also been found to be moderated by variants of the brain-derived neurotrophic factor gene, an important neuro-chemical for neural development. These variants are associated with structural and functional abnormalities in the hippocampus, including the HPA axis, which is consistent with findings of MDD patients experiencing symptoms of memory biases and increased stress. [25] Other genes include variants of the FKBP5 gene, a modulator of glucocorticoid receptors, which help predict depression prognosis. [26]

Criticisms of genetic vulnerability to depression include relatively small effect sizes in relation to heritability estimates and difficulty in replication of studies. [27] Additionally, given the wide variation of genes that increase the risk of depression, there is no set consensus on which specific gene creates predispositions to the onset of depression, moreover, establishing depression risk as a heritable component. [28] In fact, the Genome Wide Association has placed an emphasis for exploration on the mutual influence of environmental factors and genes on depression risk given that genetic risk is not necessary for onset of depression. [29]

Genetic predispositions and Cognition

Research has shown that short variant gene of 5HTTLPR is linked to negative recall, attentional and interpretive biases, all of which are known to contribute to negative evaluations of the self, world and future. For example, Hayden et al. (2014) showed that children possessing this gene carried out greater negative processing on a self-referential coding task (a measure of self-schema) following a negative mood induction (by watching sad videos) compared to children with different genotypes thus indicating the association of the gene with biases in information processing. [30]

These biases have been explained by highlighting that the 5HTTLPR polymorphism increases the reactivity of the amygdala, the part of the brain which is responsible for our emotional processing including evaluation and storage of emotionally charged events. [31] This heightened activity leads to increased attentional resources on adverse stressors manifesting a negative attentional bias and exaggerated reactions in mood. [32] This selective focus hence ends up promoting cognitive distortions like overgeneralisation and consequently dysfunctional attitudes about the self, world and future.

Neurophysiology and Cognition

The role of the amygdala is vital in understanding the onset of depression. Its function has been known to be influenced by serotonergic dysfunction (low levels of serotonin) which is primarily associated with the 5HTTLPR gene. [33]

This gene polymorphism promotes hyperactivity of the amygdala through decreased pre-frontal cortex activity following the exposure to negative stimuli. [34] The pre-frontal cortex (PFC) plays a key role in assessing stimuli, decision-making and inhibiting behaviour as a result of emotional processing of the amygdala. [35] This means diminished cognitive control from the PFC and hyperactivity of the amygdala would result in increased emotional appraisal of events and failure to inhibit negatively biased cognitions. As a result, MDD patients perceive stimuli and base decisions about themselves, the world and the future through an negatively distorted emotional lens. [36]

The disregulation of Hypothalamic-pituitary-adrenal axis has also been consistent in these findings. [37] The hyperactivity of the amygdala can lead to excessive cortisol production which has known to solidify memory consolidation. [38] Increased memory consolidation while experiencing an emotional stressor means increased attentional resources on the adverse memory which in turn contribute to negative schema formation about a particular event as well as prolong re-enforcement of negative beliefs. [39]

Re-imagined cognitive model of depression

Given the findings of biological and neurophysiological correlations to negative cognition, Beck draws a pragmatic relationship between the different levels to re-imagine and expand the cognitive model of depression.

Expanded Cognitive Model based on genes New cognitive model based on genetic diathesis.png
Expanded Cognitive Model based on genes

According to Beck, genetic diathesis, usually manifesting in the form of the short variant of the 5HTTLPR gene, leads to excessive reactivity of the amygdala and decreased PFC activity emphasising an increased focus on negative emotional reactivity and their deficient reappraisal. This triggers negative attentional biases formulating cognitive distortions like selective abstraction and magnification establishing negative cognitive perceptions. A collection of these perceptions form dysfunctional attitudes and beliefs about oneself, the world and the future in the form of negative schemas (framework of a collection of ideas). Repeated processing of events in this way strengthen the content of these schemas. The negative perceptions and interpretations also set off the HPA axis producing cortisol stimulating the consolidation of negative memories and emotions associated with the adverse stimuli. As a result, the cognitive triad is enabled and depressive symptoms manifest and persist. [40]

Criticisms

An obvious criticism of this model is that it mainly focuses on the 5HTTLPR gene as the genetic diathesis whereas other genes have also been known to be associated with depressive symptoms. Additionally, most of the claims made in the theory are based on correlations. Moreover, one does not know whether it is decrease in serotonin or hyperactivity of the amygdala that directly causes depression. It is also unidentified how the 5HTTLPR gene causes the hyperactivity of the amygdala. A study also showed patients treated with cognitive therapy compared to those treated pharmaceutically did not show increase in cognitive depression symptoms when made to deplete their serotonin levels. [41] This highlights an existing complex relationship between serotonin and cognition that requires further clarification. [40]

See also

Related Research Articles

<span class="mw-page-title-main">Anxiety</span> Unpleasant state of inner turmoil over anticipated events

Anxiety is an emotion which is characterised by an unpleasant state of inner turmoil and includes feelings of dread over anticipated events. Anxiety is different from fear in that fear is defined as the emotional response to a present threat, whereas anxiety is the anticipation of a future one. It is often accompanied by nervous behavior such as pacing back and forth, somatic complaints, and rumination.

<span class="mw-page-title-main">Cognitive behavioral therapy</span> Type of therapy to improve mental health

Cognitive behavioral therapy (CBT) is a psycho-social intervention that aims to reduce symptoms of various mental health conditions, primarily depression and anxiety disorders. Cognitive behavioral therapy is one of the most effective means of treatment for substance abuse and co-occurring mental health disorders. CBT focuses on challenging and changing cognitive distortions and their associated behaviors to improve emotional regulation and develop personal coping strategies that target solving current problems. Though it was originally designed to treat depression, its uses have been expanded to include many issues and the treatment of many mental health conditions, including anxiety, substance use disorders, marital problems, ADHD, and eating disorders. CBT includes a number of cognitive or behavioral psychotherapies that treat defined psychopathologies using evidence-based techniques and strategies.

<span class="mw-page-title-main">Major depressive disorder</span> Mental disorder involving persistent low mood, low self-esteem, and loss of interest

Major depressive disorder (MDD), also known as clinical depression, is a mental disorder characterized by at least two weeks of pervasive low mood, low self-esteem, and loss of interest or pleasure in normally enjoyable activities. Introduced by a group of US clinicians in the mid-1970s, the term was adopted by the American Psychiatric Association for this symptom cluster under mood disorders in the 1980 version of the Diagnostic and Statistical Manual of Mental Disorders (DSM-III), and has become widely used since.

<span class="mw-page-title-main">Mood swing</span> Extreme or rapid change in mood

A mood swing is an extreme or sudden change of mood. Such changes can play a positive part in promoting problem solving and in producing flexible forward planning, or be disruptive. When mood swings are severe, they may be categorized as part of a mental illness, such as bipolar disorder, where erratic and disruptive mood swings are a defining feature.

<span class="mw-page-title-main">Serotonin transporter</span> Mammalian protein found in humans

The serotonin transporter also known as the sodium-dependent serotonin transporter and solute carrier family 6 member 4 is a protein that in humans is encoded by the SLC6A4 gene. SERT is a type of monoamine transporter protein that transports the neurotransmitter serotonin from the synaptic cleft back to the presynaptic neuron, in a process known as serotonin reuptake.

Generalized anxiety disorder (GAD) is a mental and behavioral disorder, specifically an anxiety disorder characterized by excessive, uncontrollable and often irrational worry about events or activities. Worry often interferes with daily functioning, and individuals with GAD are often overly concerned about everyday matters such as health, finances, death, family, relationship concerns, or work difficulties. Symptoms may include excessive worry, restlessness, trouble sleeping, exhaustion, irritability, sweating, and trembling.

Depressive realism is the hypothesis developed by Lauren Alloy and Lyn Yvonne Abramson that depressed individuals make more realistic inferences than non-depressed individuals. Although depressed individuals are thought to have a negative cognitive bias that results in recurrent, negative automatic thoughts, maladaptive behaviors, and dysfunctional world beliefs, depressive realism argues not only that this negativity may reflect a more accurate appraisal of the world but also that non-depressed individuals' appraisals are positively biased.

Neuroticism is a personality trait associated with negative emotions. It is one of the Big Five traits. Individuals with high scores on neuroticism are more likely than average to experience such feelings as anxiety, worry, fear, anger, frustration, envy, jealousy, pessimism, guilt, depressed mood, and loneliness. Such people are thought to respond worse to stressors and are more likely to interpret ordinary situations, such as minor frustrations, as appearing hopelessly difficult. Their behavioral responses may include procrastination, substance use, and other maladaptive behaviors, which may aid in relieving negative emotions and generating positive ones.

5-HTTLPR is a degenerate repeat polymorphic region in SLC6A4, the gene that codes for the serotonin transporter. Since the polymorphism was identified in the middle of the 1990s, it has been extensively investigated, e.g., in connection with neuropsychiatric disorders. A 2006 scientific article stated that "over 300 behavioral, psychiatric, pharmacogenetic and other medical genetics papers" had analyzed the polymorphism. While often discussed as an example of gene-environment interaction, this contention is contested.

Rs6265, also called Val66Met or G196A, is a gene variation, a single nucleotide polymorphism (SNP) in the BDNF gene that codes for brain-derived neurotrophic factor.

Behavioral theories of depression explain the etiology of depression based on the behavioural sciences, and they form the basis for behavioral therapies for depression.

Arbitrary inference is a classic tenet of cognitive therapy created by Aaron T. Beck in 1979. He defines the act of making an arbitrary inference as the process of drawing a conclusion without sufficient evidence, or without any evidence at all. In cases of depression, Beck found that individuals may be more prone to cognitive distortions, and make arbitrary inferences more often. These inferences could be general and/or in reference to the effectiveness of their medicine or treatment. Arbitrary inference is one of numerous specific cognitive distortions identified by Beck that can be commonly presented in people with anxiety, depression, and psychological impairments.

<span class="mw-page-title-main">Rumination (psychology)</span> Focused attention

Rumination is the focused attention on the symptoms of one's mental distress, and on its possible causes and consequences, as opposed to its solutions, according to the Response Styles Theory proposed by Nolen-Hoeksema in 1998.

Scientific studies have found that different brain areas show altered activity in humans with major depressive disorder (MDD), and this has encouraged advocates of various theories that seek to identify a biochemical origin of the disease, as opposed to theories that emphasize psychological or situational causes. Factors spanning these causative groups include nutritional deficiencies in magnesium, vitamin D, and tryptophan with situational origin but biological impact. Several theories concerning the biologically based cause of depression have been suggested over the years, including theories revolving around monoamine neurotransmitters, neuroplasticity, neurogenesis, inflammation and the circadian rhythm. Physical illnesses, including hypothyroidism and mitochondrial disease, can also trigger depressive symptoms.

Terrie Edith Moffitt is an American-British clinical psychologist who is best known for her pioneering research on the development of antisocial behavior and for her collaboration with colleague and partner Avshalom Caspi in research on gene-environment interactions in mental disorders.

A cognitive vulnerability in cognitive psychology is an erroneous belief, cognitive bias, or pattern of thought that predisposes an individual to psychological problems. The vulnerability exists before the symptoms of a psychological disorder appear. After the individual encounters a stressful experience, the cognitive vulnerability shapes a maladaptive response that increases the likelihood of a psychological disorder.

The genetic influences of post-traumatic stress disorder (PTSD) are not understood well due to the limitations of any genetic study of mental illness; in that, it cannot be ethically induced in selected groups. Because of this, all studies must use naturally occurring groups with genetic similarities and differences, thus the amount of data is limited. Still, genetics play some role in the development of PTSD.

Immuno-psychiatry, according to Pariante, is a discipline that studies the connection between the brain and the immune system. It differs from psychoneuroimmunology by postulating that behaviors and emotions are governed by peripheral immune mechanisms. Depression, for instance, is seen as malfunctioning of the immune system.

<span class="mw-page-title-main">Biology of bipolar disorder</span> Biological Study Of Bipolar Disorder

Bipolar disorder is an affective disorder characterized by periods of elevated and depressed mood. The cause and mechanism of bipolar disorder is not yet known, and the study of its biological origins is ongoing. Although no single gene causes the disorder, a number of genes are linked to increase risk of the disorder, and various gene environment interactions may play a role in predisposing individuals to developing bipolar disorder. Neuroimaging and postmortem studies have found abnormalities in a variety of brain regions, and most commonly implicated regions include the ventral prefrontal cortex and amygdala. Dysfunction in emotional circuits located in these regions have been hypothesized as a mechanism for bipolar disorder. A number of lines of evidence suggests abnormalities in neurotransmission, intracellular signalling, and cellular functioning as possibly playing a role in bipolar disorder.

In the context of the nature-nurture debate, interactionism is the view that all human behavioral traits develop from the interaction of both "nature" and "nurture", that is, from both genetic and environmental factors. This view further holds that genetic and environmental influences on organismal development are so closely interdependent that they are inseparable from one another. Historically, it has often been confused with the statistical concept of gene-environment interaction. Historically, interactionism has presented a limited view of the manner in which behavioral traits develop, and has simply demonstrated that "nature" and "nurture" are both necessary. Among the first biologists to propose an interactionist theory of development was Daniel Lehrman. Since then, numerous interactionist perspectives have been proposed, and the contradictions between many of these perspectives has led to much controversy in evolutionary psychology and behavioral genetics. Proponents of various forms of interactionist perspectives include Philip Kitcher, who refers to his view as "causal democracy", and Susan Oyama, who describes her perspective as "constructive interactionism". Critics of interactionism include major figures in behavioral genetics such as Arthur Jensen, Robert Plomin, and philosopher Neven Sesardic.

References

  1. 1 2 Gross, Richard (2015). Psychology: The Science of Mind and Behaviour 7th Edition. Hodder Education. pp. 796, 797. ISBN   978-1-4718-2973-4.
  2. Cardwell, Flanagan, Mike, Cara (2015). Psychology A Level Year 1 and AS: The Complete Companion Student Book. OUP. p. 108. ISBN   978-0-19-833864-2.{{cite book}}: CS1 maint: multiple names: authors list (link)
  3. Beck, Aaron, T.; Rush, A. John; Shaw, Brian F.; Emery, Gary (1987). Cognitive Therapy of Depression. Guilford Press. ISBN   978-0-89862-919-4.{{cite book}}: CS1 maint: multiple names: authors list (link)
  4. "Overview of Beck's Cognitive Theory of Depression". www.personalityresearch.org. Retrieved 2016-03-08.
  5. "Cognitive Behavioral Therapy | CBT | Simply Psychology". www.simplypsychology.org. Retrieved 2016-10-04.
  6. Beck, Aaron T.; Steer, Robert A.; Beck, Judith S.; Newman, Cory F. (1993-06-01). "Hopelessness, Depression, Suicidal Ideation, and Clinical Diagnosis of Depression". Suicide and Life-Threatening Behavior. 23 (2): 139–145. doi:10.1111/j.1943-278X.1993.tb00378.x. ISSN   1943-278X. PMID   8342213.
  7. 1 2 Sadock, Sadock, Ruiz, Benjamin J., Virginia Alcott, Pedro (2009). Kaplan and Sadock's Comprehensive Textbook of Psychiatry. Lippincott Williams and Wilkins. ISBN   978-0-7817-6899-3.{{cite book}}: CS1 maint: multiple names: authors list (link)
  8. Davison, Neale, G.D, M (2001). Abnormal Psychology (8th Ed.) . J Wiley. ISBN   978-0-471-31811-8.{{cite book}}: CS1 maint: multiple names: authors list (link)
  9. "Cognitive Behavioral Therapy | CBT | Simply Psychology". www.simplypsychology.org. Retrieved 2016-03-08.
  10. Beck, Aaron, T (1979-01-01). Cognitive Therapy of Depression . New York: The Guilford Press. pp.  11. ISBN   978-0-89862-919-4.{{cite book}}: CS1 maint: multiple names: authors list (link)
  11. "Overview of Beck's Cognitive Theory of Depression". www.personalityresearch.org. Retrieved 2016-10-04.
  12. "Explaining Depression - Beck's Cognitive Triad | Psychology | tutor2u". www.tutor2u.net. Retrieved 2016-10-04.
  13. 1 2 3 Beckham, Ernest Edward; Leber, William R.; Watkins, John T.; Boyer, Jenny L.; Cook, Jacque B. (1986). "Development of an instrument to measure Beck's cognitive triad: The Cognitive Triad Inventory". Journal of Consulting and Clinical Psychology. 54 (4): 566–567. doi:10.1037/0022-006x.54.4.566. PMID   3745613.
  14. Beck A.T. (1988). "Beck Hopelessness Scale." The Psychological Corporation.
  15. Rosenberg, M. (1965). Society and the adolescent self-image. Princeton, NJ: Princeton University Press. online pdf here: https://www.docdroid.net/Vt9xpBg/society-and-the-adolescent-self-image-morris-rosenberg-1965.pdf
  16. Kaslow, Nadine J.; Stark, Kevin D.; Printz, Brian; Livingston, Ronnie; Tsai, Shung Ling (1992-12-01). "Cognitive Triad Inventory for Children: Development and Relation to Depression and Anxiety". Journal of Clinical Child Psychology. 21 (4): 339–347. doi:10.1207/s15374424jccp2104_3. ISSN   0047-228X.
  17. Clark, David A.; Beck, Aaron T.; Alford, Brad A.; Bieling, Peter J.; Segal, Zindel V. (2000-01-01). "Scientific Foundations of Cognitive Theory and Therapy of Depression". Journal of Cognitive Psychotherapy. 14 (1): 100–106. doi:10.1891/0889-8391.14.1.100. ISSN   0889-8391.
  18. Hamann, Stephan (June 2005). "Blue genes: wiring the brain for depression". Nature Neuroscience. 8 (6): 701–703. doi:10.1038/nn0605-701. ISSN   1546-1726. PMID   15917831.
  19. Matei, Adrienne (2024-03-04). "Oversensitive and overreactive: what is nervous system dysregulation and how can it be resolved?". The Guardian. ISSN   0261-3077 . Retrieved 2024-03-21.
  20. Albert, Kimberly M.; Newhouse, Paul A. (2019-05-07). "Estrogen, Stress, and Depression: Cognitive and Biological Interactions". Annual Review of Clinical Psychology. 15 (1): 399–423. doi:10.1146/annurev-clinpsy-050718-095557. ISSN   1548-5943. PMC   9673602 . PMID   30786242.
  21. Caspi, Avshalom; Sugden, Karen; Moffitt, Terrie E.; Taylor, Alan; Craig, Ian W.; Harrington, HonaLee; McClay, Joseph; Mill, Jonathan; Martin, Judy; Braithwaite, Antony; Poulton, Richie (2003-07-18). "Influence of Life Stress on Depression: Moderation by a Polymorphism in the 5-HTT Gene". Science. 301 (5631): 386–389. Bibcode:2003Sci...301..386C. doi:10.1126/science.1083968. ISSN   0036-8075. PMID   12869766.
  22. "CORRECTION". Archives of General Psychiatry. 35 (9): 1107. 1978-09-01. doi:10.1001/archpsyc.1978.01770330081007. ISSN   0003-990X.
  23. Vrshek-Schallhorn, Suzanne; Mineka, Susan; Zinbarg, Richard E.; Craske, Michelle G.; Griffith, James W.; Sutton, Jonathan; Redei, Eva E.; Wolitzky-Taylor, Kate; Hammen, Constance; Adam, Emma K. (May 2014). "Refining the Candidate Environment: Interpersonal Stress, the Serotonin Transporter Polymorphism, and Gene-Environment Interactions in Major Depression". Clinical Psychological Science. 2 (3): 235–248. doi:10.1177/2167702613499329. ISSN   2167-7026. PMC   4950519 . PMID   27446765.
  24. Karg, Katja; Burmeister, Margit; Shedden, Kerby; Sen, Srijan (2011-05-02). "The Serotonin Transporter Promoter Variant (5-HTTLPR), Stress, and Depression Meta-analysis Revisited: Evidence of Genetic Moderation". Archives of General Psychiatry. 68 (5): 444–454. doi:10.1001/archgenpsychiatry.2010.189. ISSN   0003-990X. PMC   3740203 . PMID   21199959.
  25. Lee, Kyu Young; Jeong, Seong Hoon; Kim, Se Hyun; Ahn, Yong Min; Kim, Yong Sik; Jung, Hee Yeon; Bang, Yang Weon; Joo, Eun-Jeong (2014-04-11). "Genetic Role of BDNF Val66Met and 5-HTTLPR Polymorphisms on Depressive Disorder". Psychiatry Investigation. 11 (2): 192–199. doi:10.4306/pi.2014.11.2.192. ISSN   1738-3684. PMC   4023095 . PMID   24843376.
  26. Menke, A.; Klengel, T.; Rubel, J.; Brückl, T.; Pfister, H.; Lucae, S.; Uhr, M.; Holsboer, F.; Binder, E. B. (April 2013). "Genetic variation in FKBP5 associated with the extent of stress hormone dysregulation in major depression". Genes, Brain and Behavior. 12 (3): 289–296. doi:10.1111/gbb.12026. ISSN   1601-1848. PMID   23406438.
  27. Ioannidis, John P.A.; Trikalinos, Thomas A.; Jhoury, Muin J. (2006-08-07). "Implications of Small Effect Sizes of Individual Genetic Variants on the Design and Interpretation of Genetic Association Studies of Complex Diseases". American Journal of Epidemiology . 164 (7): 609–614. doi: 10.1093/aje/kwj259 . PMID   16893921 . Retrieved 2024-03-21.
  28. Uher, R. (December 2008). "The implications of gene–environment interactions in depression: will cause inform cure?". Molecular Psychiatry. 13 (12): 1070–1078. doi:10.1038/mp.2008.92. ISSN   1476-5578. PMID   18679406.
  29. Jansen, R.; Penninx, B. W. J. H.; Madar, V.; Xia, K.; Milaneschi, Y.; Hottenga, J. J.; Hammerschlag, A. R.; Beekman, A.; van der Wee, N.; Smit, J. H.; Brooks, A. I.; Tischfield, J.; Posthuma, D.; Schoevers, R.; van Grootheest, G. (March 2016). "Gene expression in major depressive disorder". Molecular Psychiatry. 21 (3): 339–347. doi:10.1038/mp.2015.57. ISSN   1476-5578. PMID   26008736.
  30. Goldstein, Brandon L.; Hayden, Elizabeth P.; Klein, Daniel N. (2015-11-17). "Stability of self-referent encoding task performance and associations with change in depressive symptoms from early to middle childhood". Cognition and Emotion. 29 (8): 1445–1455. doi:10.1080/02699931.2014.990358. ISSN   0269-9931. PMC   4476963 . PMID   25530070.
  31. "Web of Science". www.webofscience.com. Retrieved 2024-03-21.
  32. Victor, Teresa A.; Furey, Maura L.; Fromm, Stephen J.; Öhman, Arne; Drevets, Wayne C. (2010-11-01). "Relationship Between Amygdala Responses to Masked Faces and Mood State and Treatment in Major Depressive Disorder". Archives of General Psychiatry. 67 (11): 1128–1138. doi:10.1001/archgenpsychiatry.2010.144. ISSN   0003-990X. PMC   3253452 . PMID   21041614.
  33. Alexander, N.; Wankerl, M.; Hennig, J.; Miller, R.; Zänkert, S.; Steudte-Schmiedgen, S.; Stalder, T.; Kirschbaum, C. (September 2014). "DNA methylation profiles within the serotonin transporter gene moderate the association of 5-HTTLPR and cortisol stress reactivity". Translational Psychiatry. 4 (9): e443. doi:10.1038/tp.2014.88. ISSN   2158-3188. PMC   4203016 . PMID   25226552.
  34. Mann, J. John; Huang, Yung-yu; Underwood, Mark D.; Kassir, Suham A.; Oppenheim, Sara; Kelly, Thomas M.; Dwork, Andrew J.; Arango, Victoria (2000). "A Serotonin Transporter Gene Promoter Polymorphism (5-HTTLPR) and Prefrontal Cortical Binding in Major Depression and Suicide". Archives of General Psychiatry. 57 (8): 729–738. doi:10.1001/archpsyc.57.8.729. PMID   10920459 . Retrieved 2024-03-21.
  35. Menon, Vinod; D’Esposito, Mark (January 2022). "The role of PFC networks in cognitive control and executive function". Neuropsychopharmacology. 47 (1): 90–103. doi:10.1038/s41386-021-01152-w. ISSN   1740-634X. PMC   8616903 . PMID   34408276.
  36. Pezawas, Lukas; Meyer-Lindenberg, Andreas; Drabant, Emily M.; Verchinski, Beth A.; Munoz, Karen E.; Kolachana, Bhaskar S.; Egan, Michael F.; Mattay, Venkata S.; Hariri, Ahmad R.; Weinberger, Daniel R. (June 2005). "5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression". Nature Neuroscience. 8 (6): 828–834. doi:10.1038/nn1463. ISSN   1546-1726. PMID   15880108.
  37. Miller, R.; Wankerl, M.; Stalder, T.; Kirschbaum, C.; Alexander, N. (September 2013). "The serotonin transporter gene-linked polymorphic region (5-HTTLPR) and cortisol stress reactivity: a meta-analysis". Molecular Psychiatry. 18 (9): 1018–1024. doi:10.1038/mp.2012.124. ISSN   1476-5578. PMID   22945032.
  38. Wolf, O T.; Kuhlmann, S; Buss, C; Hellhammer, D H.; Kirschbaum, C (December 2004). "Cortisol and Memory Retrieval in Humans: Influence of Emotional Valence". Annals of the New York Academy of Sciences. 1032 (1): 195–197. Bibcode:2004NYASA1032..195W. doi:10.1196/annals.1314.019. ISSN   0077-8923. PMID   15677409.
  39. Hansson, Pia Berner; Murison, Robert; Lund, Anders; Hammar, Åsa (December 2013). "Cognitive functioning and cortisol suppression in recurrent major depression". PsyCh Journal. 2 (3): 167–174. doi:10.1002/pchj.29. ISSN   2046-0252. PMID   26271361.
  40. 1 2 Beck, Aaron T.; Haigh, Emily A.P. (2014-03-28). "Advances in Cognitive Theory and Therapy: The Generic Cognitive Model". Annual Review of Clinical Psychology. 10 (1): 1–24. doi:10.1146/annurev-clinpsy-032813-153734. ISSN   1548-5943. PMID   24387236.
  41. O'Reardon, John P.; Chopra, Mohit P.; Bergan, Alexandra; Gallop, Robert; DeRubeis, Robert J.; Crits-Christoph, Paul (2004-05-01). "Response to tryptophan depletion in major depression treated with either cognitive therapy or selective serotonin reuptake inhibitor antidepressants". Biological Psychiatry. 55 (9): 957–959. doi:10.1016/j.biopsych.2003.12.020. ISSN   1873-2402. PMID   15110741.